Skip to content

PeerfordResearch intelligence

Countries
Institutions
Researchers
Fields
Rankings
Compare
Commons

Search institutions, scholars, countries and publications

Countries
Institutions
Researchers
Fields
Rankings
Compare

CommonsWhere researchers talk about their work

Search institutions, scholars, countries and publications

Every figure here is counted by Peerford from the works themselves, the same way for every institution.

Browse

Countries
Institutions
Researchers
Fields
Rankings
Commons, for researchers

About

How Peerford counts
Compare institutions
Privacy
Terms of use

Contact

hello@peerford.com
https://wa.me/peerford · WhatsApp

Language

English
FrançaisFrench
PortuguêsPortuguese
العربيةArabic

Theme

SystemLightDark

Goodness Ogechi Osondu-chuka · Peerford

University of Nigeria / Scholars

GO

Goodness Ogechi Osondu-chuka

University of Nigeria

Publishing since 2021, latest 2022

Applied Microbiology and Biotechnology
Infectious Diseases
Molecular Medicine
Neurology
Pollution

ORCID 0000-0003-3112-5626
Their record on OpenAlex
Download CV:PDF Word
Who they write with Where their co-authors are Every publication
Is this you? Sign in to edit your profile

Publications: 22021–2022
Citations: 21to those papers
h-index: 2i10-index 1
Field-weighted impact: 0.561.00 is the world average
World top 10%: 0%0 of 2 scored papers
Open access: 100%2 papers free to read

By year

Papers, and the citations to them

Publications, left axisCitations to that year’s papers, right axis2026 still in progress

Citations received each year

Peerford

To all their work, old papers included. Google Scholar also counts citations from theses, books and web pages, so its line runs higher.

What they work on

From the classification of each paper

Subfields

Applied Microbiology and Biotechnology150%

Publications

2 in all

Newest Most cited Oldest Title

Search their publications by title

Antimicrobial resistance: revisiting the mechanisms of resistance
2022Access MicrobiologyJournalOpen access8 citations10.1099/acmi.ac2021.po0053
Immunobiology and nanotherapeutics of severe acute respiratory syndrome 2 (SARS-CoV-2): a current update
2021Scandinavian Journal of Infectious Diseases

Infectious Diseases150%

Molecular Medicine150%

Neurology150%

Pollution150%

Health Sciences
Life Sciences
Physical Sciences

Topics most written on

Antibiotic Resistance in Bacteria1
Antibiotic Use and Resistance1
COVID-19 Clinical Research Studies1
Long-Term Effects of COVID-191
Pharmaceutical and Antibiotic Environmental Impacts1
SARS-CoV-2 and COVID-19 Research1

Who they write with

Their most frequent co-authors, and the papers those co-authors share

Where they publish

Access Microbiology1
Scandinavian Journal of Infectious Diseases1

How it can be read

100% free to read

Gold 1 · 50%In an open-access journal
Green 1 · 50%A copy in a repository

Development goals addressed

From each paper’s title and abstract

3Good health and well-being2

Most cited

Immunobiology and nanotherapeutics of severe acute respiratory syndrome 2 (SARS-CoV-2): a current update
Scandinavian Journal of Infectious Diseases3
202113 citationsOpen access · Green
Antimicrobial resistance: revisiting the mechanisms of resistance
Access Microbiology3
20228 citationsOpen access · Gold

Journal

Open access

13 citations

10.1080/23744235.2021.1916071